Nurse Practitioner, Adult Health · Brooklyn, NY
NPI
1093212086
Since 2018
Specialty
Nurse Practitioner, Adult Health
Code 363LA2200X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
3101 Ocean Pkwy Apt 1a
Brooklyn, NY, 11235
Phone (718) 946-2481
Groups this clinician bills Medicare through
Medicare paid, 2024
$60K
874 services
Medicare patients, 2024
320
Average age 82
Drug cost, 2024
$1.9M
14,152 prescriptions
Company payments, 2025
$2,886
From 12 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Gennadiy Goldvekht was code 99213 (office e&m - established), 586 times for 283 patients. In total Gennadiy Goldvekht billed 874 services in 8 codes, and Medicare paid $60K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2018-04-06.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99213 Office E&M - Established | Office | 586 | 283 | $70.34 | $41K |
| 99214 Office E&M - Established | Office | 104 | 86 | $98.88 | $10K |
| 97129 Behavioral Health Services | Office | 72 | 46 | $16.49 | $1,187 |
| 97130 Behavioral Health Services | Office | 70 | 46 | $15.75 | $1,102 |
| 99205 Office E&M - New | Office | 35 | 35 | $170.70 | $5,975 |
By year: 2022 $44K for 602 services; 2023 $22K for 308 services; 2024 $60K for 874 services.
Medicare prescription drug claims, 2024
In 2024, the drug Gennadiy Goldvekht prescribed most often to Medicare patients was Gabapentin, with 1,684 prescriptions and refills. In total Gennadiy Goldvekht wrote 14,152 Medicare prescriptions that cost $1.9M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Gabapentin Generic | 1,684 | 1,689 | 191 | $4,131 |
| Memantine Hcl Er Memantine Hcl | 1,521 | 1,521 | 162 | $90K |
| Escitalopram Oxalate Generic | 1,366 | 1,424 | 200 | $4,443 |
| Memantine Hcl Generic | 847 | 879 | 122 | $13K |
| Sertraline Hcl Generic | 843 | 855 | 91 | $1,455 |
| Rivastigmine Generic | 823 | 839 | 113 | $70K |
| Donepezil Hcl Generic | 762 | 778 | 136 | $2,801 |
| Mirtazapine Generic | 663 | 673 | 109 | $13K |
| Trintellix Vortioxetine Hydrobromide | 653 | 654 | 86 | $310K |
| Rexulti Brexpiprazole | 615 | 615 | 82 | $914K |
| Bupropion Hcl Generic | 587 | 593 | 96 | $4,823 |
| Doxepin Hcl Generic | 564 | 566 | 85 | $89K |
| Bupropion Xl Bupropion Hcl | 451 | 461 | 62 | $3,223 |
| Clonazepam Generic | 323 | 325 | 80 | $1,318 |
| Namzaric Memantine Hcl/Donepezil Hcl | 269 | 269 | 34 | $152K |
Brand drugs: 2,317 claims; generic drugs: 11,835 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Gennadiy Goldvekht $2,886 ($2,886 in general payments such as food, travel and fees) from 12 companies. The largest payer was Otsuka America Pharmaceutical, Inc. with $964.
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. 4578.T | 23 | $964 |
| Lundbeck LLC | 16 | $431 |
| Alkermes, Inc. ALKS | 8 | $306 |
| Axsome Therapeutics, Inc. AXSM | 6 | $264 |
| Vanda Pharmaceuticals Inc. VNDA | 11 | $231 |
| Takeda Pharmaceuticals U.S.A., Inc. TAK | 9 | $201 |
| Neurocrine BioSciences, Inc. NBIX | 5 | $145 |
| E.R. Squibb & Sons, L.L.C. BMY | 3 | $107 |
| Abbvie Inc. ABBV | 3 | $78.37 |
| Teva Pharmaceuticals USA, Inc. TEVA | 3 | $74.08 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.